The Latest Headlines at American Banking and Market News
Q2 2024 Earnings Forecast for Pharvaris Issued By Leerink Partnrs (NASDAQ:PHVS)
Pharvaris (NASDAQ:PHVS – Free Report) – Research analysts at Leerink Partnrs lowered their Q2 2024 earnings estimates for Pharvaris in a report released on Wednesday, May 8th. Leerink Partnrs analyst J. Schwartz now... More of this article »
William Blair Weighs in on Planet Fitness, Inc.’s Q2 2024 Earnings (NYSE:PLNT)
Planet Fitness, Inc. (NYSE:PLNT – Free Report) – Research analysts at William Blair cut their Q2 2024 earnings estimates for shares of Planet Fitness in a note issued to investors on Thursday, May 9th. William Blair... More of this article »
Planet Fitness, Inc. to Post Q2 2024 Earnings of $0.69 Per Share, DA Davidson Forecasts (NYSE:PLNT)
Planet Fitness, Inc. (NYSE:PLNT – Free Report) – Stock analysts at DA Davidson issued their Q2 2024 earnings per share (EPS) estimates for Planet Fitness in a research note issued on Friday, May 10th. DA Davidson analyst... More of this article »
Permian Resources Co. (NASDAQ:PR) Expected to Post Q2 2024 Earnings of $0.41 Per Share
Permian Resources Co. (NASDAQ:PR – Free Report) – Investment analysts at Capital One Financial increased their Q2 2024 earnings estimates for shares of Permian Resources in a research note issued to investors on Wednesday,... More of this article »
Q2 2024 EPS Estimates for Privia Health Group, Inc. (NASDAQ:PRVA) Lifted by Analyst
Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) – Leerink Partnrs lifted their Q2 2024 EPS estimates for Privia Health Group in a research note issued to investors on Thursday, May 9th. Leerink Partnrs analyst... More of this article »
HC Wainwright Analysts Reduce Earnings Estimates for Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – HC Wainwright cut their Q2 2024 earnings per share estimates for Protagonist Therapeutics in a report issued on Thursday, May 9th. HC Wainwright analyst D.... More of this article »
Primoris Services Co. (NASDAQ:PRIM) Forecasted to Earn Q2 2024 Earnings of $0.65 Per Share
Primoris Services Co. (NASDAQ:PRIM – Free Report) – Stock analysts at DA Davidson issued their Q2 2024 EPS estimates for shares of Primoris Services in a research note issued on Friday, May 10th. DA Davidson analyst... More of this article »
Research Analysts Offer Predictions for Privia Health Group, Inc.’s Q2 2024 Earnings (NASDAQ:PRVA)
Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) – Research analysts at William Blair lowered their Q2 2024 earnings per share estimates for shares of Privia Health Group in a research note issued to investors on... More of this article »
Q2 2024 EPS Estimates for Quanterix Co. Raised by Leerink Partnrs (NASDAQ:QTRX)
Quanterix Co. (NASDAQ:QTRX – Free Report) – Leerink Partnrs boosted their Q2 2024 earnings per share estimates for Quanterix in a research note issued on Wednesday, May 8th. Leerink Partnrs analyst P. Souda now expects... More of this article »
Zacks Research Analysts Raise Earnings Estimates for Royal Caribbean Cruises Ltd. (NYSE:RCL)
Royal Caribbean Cruises Ltd. (NYSE:RCL – Free Report) – Analysts at Zacks Research boosted their Q2 2024 earnings per share (EPS) estimates for Royal Caribbean Cruises in a research note issued on Thursday, May 9th.... More of this article »
HC Wainwright Analysts Boost Earnings Estimates for uniQure (NASDAQ:QURE)
uniQure (NASDAQ:QURE – Free Report) – Research analysts at HC Wainwright boosted their Q2 2024 earnings per share (EPS) estimates for shares of uniQure in a research report issued on Wednesday, May 8th. HC Wainwright... More of this article »
Analysts Offer Predictions for R1 RCM Inc.’s Q2 2024 Earnings (NASDAQ:RCM)
R1 RCM Inc. (NASDAQ:RCM – Free Report) – Research analysts at Leerink Partnrs raised their Q2 2024 EPS estimates for shares of R1 RCM in a research note issued to investors on Wednesday, May 8th. Leerink Partnrs analyst... More of this article »
Revolution Medicines, Inc. Forecasted to Post Q2 2024 Earnings of ($0.76) Per Share (NASDAQ:RVMD)
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Investment analysts at Wedbush reduced their Q2 2024 EPS estimates for shares of Revolution Medicines in a research report issued to clients and investors on ... More of this article »